AI can find a new drug candidate in days. So why does it take years to reach you?
@biogerontology says people “overestimate the capabilities of AI and underestimate the complexity of biology.” For some conditions, trials still take a decade.
That gap is now on
@OpenAI's radar. This week, it bought Orchestra Bio, which uses AI agents to keep drug programmes on track.